search
Back to results

TETRAGRIP II - Usability Trial of an FES Orthosis for People With Tetraplegia.

Primary Purpose

Spinal Cord Injuries, Tetraplegia

Status
Completed
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
TetraGrip II system
Sponsored by
Bournemouth University
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional basic science trial for Spinal Cord Injuries

Eligibility Criteria

18 Years - 90 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Have a spinal cord injury that has resulted in tetraplegia affecting hand function.
  • Minimal spasticity of wrist muscle.
  • Able to do shoulder elevation.
  • Upper limb passive range of motion should be within normal limit.
  • Age group: 18 years and above.
  • Able to understand and comply with assessment procedures.
  • Able to give informed consent.
  • Able to produce a muscle contraction using electrical stimulation in sufficient muscles produce a functional grip.

Exclusion Criteria:

  • Using a cardiac pacemaker, defibrillator or other sensitive implanted device.
  • Pregnant or planning to become pregnant over the course of the study.
  • A history of poorly controlled epilepsy.
  • If there is malignancy on the hand or arm.
  • If younger than 18
  • Severe contracture of wrist and finger joints.
  • Painful shoulder.
  • Suffering from significant autonomic dysreflexia in response to FES.

Sites / Locations

  • Salisbury District Hospital

Outcomes

Primary Outcome Measures

Grasp Release Test (GRT)
Test to be completed both with and without the device - exercise daily for 30 minutes, building up to 60 minutes over a four week period
Grasp Release Test (GRT)
Test to be completed both with and without the device - exercise daily for 30 minutes, building up to 60 minutes over a four week period
Grasp Release Test (GRT)
Test to be completed both with and without the device - exercise daily for 30 minutes, building up to 60 minutes over a four week period

Secondary Outcome Measures

Measurement of palmar grip
Test to be completed both with and without the device
Measurement of pinch grip
Test to be completed both with and without the device
Measurement of palmar grip
Test to be completed both with and without the device
Measurement of pinch grip
Test to be completed both with and without the device
Measurement of palmar grip
Test to be completed both with and without the device
Measurement of pinch grip
Test to be completed both with and without the device

Full Information

First Posted
June 23, 2021
Last Updated
November 10, 2022
Sponsor
Bournemouth University
Collaborators
Salisbury NHS Foundation Trust
search

1. Study Identification

Unique Protocol Identification Number
NCT04964635
Brief Title
TETRAGRIP II - Usability Trial of an FES Orthosis for People With Tetraplegia.
Official Title
TETRAGRIP II - Usability Trial of an FES Orthosis for People With Tetraplegia.
Study Type
Interventional

2. Study Status

Record Verification Date
November 2022
Overall Recruitment Status
Completed
Study Start Date
October 26, 2021 (Actual)
Primary Completion Date
August 31, 2022 (Actual)
Study Completion Date
August 31, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Bournemouth University
Collaborators
Salisbury NHS Foundation Trust

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Functional Electrical Stimulation is an established technique in which small electrical impulses are used to cause a contraction in muscles and thereby enable movement, in people with neurological or musculoskeletal problems who are unable to undertake those movements themselves. People with spinal cord injuries of the neck at C5, C6 and C7 account for 35% of all spinal cord injuries. Despite this, there is only one commercial FES (Functional Electrical Stimulation) based orthosis currently available. Even that has limitations in that it as it has a single size rigid exoskeleton it does not fit all people who could benefit and also due to its rigidity it does not allow people with lower injuries to utilise any remaining tenodesis grip. As a result, it is not widely used within the spinal injured communities. Therefore what is required is a more flexible system that can benefit a larger number of people whilst still being affordable within the constraints of the NHS. A previous INSPIRE funded project, TETRAGRIP I demonstrated that a surface FES system controlled by an inertial sensor, measuring movement of the opposite shoulder, could meet this specification and was successfully tried on two people with tetraplegia. What is now required is a more detailed study in which the principle components of that system are incorporated into a practical device suitable for use at home without clinical supervision. It is therefore proposed to develop and build such a system and to conduct extended home based trials in three people with tetraplegia.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Spinal Cord Injuries, Tetraplegia

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
4 (Actual)

8. Arms, Groups, and Interventions

Intervention Type
Device
Intervention Name(s)
TetraGrip II system
Intervention Description
This main aim of this whole research project is to evaluate the performance of the TetraGrip II system in improving the upper limb functions in people with C4-C7 tetraplegia i.e. people who have damaged their spinal cord in the neck resulting in loss of function in all four limbs. The Tetragrip system uses a technique called Functional Electrical Stimulation (FES) in which small electrical impulses are used to activate paralysed muscles and hence provide movement. The stimulation is controlled by sensors which measure the movement of the other shoulder and enable the person to regain the use of their hand via stimulating electrodes placed on the skin over the relevant muscles. The feasibility of using this FES based system in restoring the upper arm functions will be evaluated by clinically trying the device on participants with C4-C7 tetraplegia.
Primary Outcome Measure Information:
Title
Grasp Release Test (GRT)
Description
Test to be completed both with and without the device - exercise daily for 30 minutes, building up to 60 minutes over a four week period
Time Frame
Start of study - 30 minutes building up to 60 minutes over a four week period
Title
Grasp Release Test (GRT)
Description
Test to be completed both with and without the device - exercise daily for 30 minutes, building up to 60 minutes over a four week period
Time Frame
At the end of the clinical phase (week 10) - 30 minutes building up to 60 minutes over a four week period
Title
Grasp Release Test (GRT)
Description
Test to be completed both with and without the device - exercise daily for 30 minutes, building up to 60 minutes over a four week period
Time Frame
At the end of the home phase for participants taking the device home (week 18) - 30 minutes building up to 60 minutes over a four week period
Secondary Outcome Measure Information:
Title
Measurement of palmar grip
Description
Test to be completed both with and without the device
Time Frame
At the start of the study - 30 minutes
Title
Measurement of pinch grip
Description
Test to be completed both with and without the device
Time Frame
At the start of the study - 30 minutes
Title
Measurement of palmar grip
Description
Test to be completed both with and without the device
Time Frame
At the end of the clinical phase (week 10) - 30 minutes
Title
Measurement of pinch grip
Description
Test to be completed both with and without the device
Time Frame
At the end of the clinical phase (week 10) - 30 minutes
Title
Measurement of palmar grip
Description
Test to be completed both with and without the device
Time Frame
At the end of the home phase for participants taking the device home (week 18) - 30 minutes
Title
Measurement of pinch grip
Description
Test to be completed both with and without the device
Time Frame
At the end of the home phase for participants taking the device home (week 18) - 30 minutes
Other Pre-specified Outcome Measures:
Title
Two Point Discrimination Test
Description
Test to be completed both with and without the device
Time Frame
At the start of the study
Title
Two Point Discrimination Test
Description
Test to be completed both with and without the device
Time Frame
At the end of the clinical phase (week 10)
Title
Two Point Discrimination Test
Description
Test to be completed both with and without the device
Time Frame
At the end of the home phase for participants taking the device home (week 18)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Have a spinal cord injury that has resulted in tetraplegia affecting hand function. Minimal spasticity of wrist muscle. Able to do shoulder elevation. Upper limb passive range of motion should be within normal limit. Age group: 18 years and above. Able to understand and comply with assessment procedures. Able to give informed consent. Able to produce a muscle contraction using electrical stimulation in sufficient muscles produce a functional grip. Exclusion Criteria: Using a cardiac pacemaker, defibrillator or other sensitive implanted device. Pregnant or planning to become pregnant over the course of the study. A history of poorly controlled epilepsy. If there is malignancy on the hand or arm. If younger than 18 Severe contracture of wrist and finger joints. Painful shoulder. Suffering from significant autonomic dysreflexia in response to FES.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ian Swain, Professor
Organizational Affiliation
Professor in Technology & Design
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Paul Taylor, Professor
Organizational Affiliation
Consultant Clinical Scientist - Salisbury District Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Salisbury District Hospital
City
Salisbury
State/Province
Wiltshire
ZIP/Postal Code
SP2 8BJ
Country
United Kingdom

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

TETRAGRIP II - Usability Trial of an FES Orthosis for People With Tetraplegia.

We'll reach out to this number within 24 hrs